Coreline Soft, a Korean medical artificial intelligence (AI) company listed on Kosdaq, said on Thursday that it signed a supply agreement with Meridian Healthcare LLC (MHC), a healthcare services firm based in Dubai, the UAE, for its AI solution AVIEW.

Coreline Soft will supply nine AVIEW products to MHC, including the AI chest simultaneous diagnosis solution AVIEW LCS PLUS.

With this agreement, CorelineSoft will leverage MHC's network, which has a large share of the Middle East healthcare market.

MHC has a network of leading hospitals in the Middle East and Africa, and works with governments, private companies, and educational institutions.

Under the agreement, MHC secured exclusive rights to distribute Coreline Soft’s products in seven countries across the Middle East region. The products will be supplied to local healthcare organizations in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the UAE, and Egypt. The term of the agreement runs from October 10, 2023 to October 10, 2026.

The foundation that owns MHC also operates an imaging center in Dubai, which recently implemented AVIEW. Burjeel, an early detection hospital in Abu Dhabi is also in the process of purchasing AVIEW.

"By collaborating with MHC, we will actively expand our overseas business to Asia, Europe, and Africa, which are connected by the Middle East," said Kim Jin-kook, CEO of Coreline Soft. "With the lung cancer screening project in Egypt, a country with a population of over 100 million, neighboring countries are also showing active interest. By partnering with leading hospitals, we will expand our market share in each region and country."

"Our agreement with Coreline Soft is the result of a digital transformation that MHC has been preparing for a long time." said Prof. Ahmed El-Serafi, MD, Chief Executive Officer of MHC. "By distributing Coreline soft’s products in the Middle East and Africa, MHC will rapidly expand its healthcare AI footprint in the region."